COGNITION THERAPEUTICS INC

Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.

CGTX | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2403 SIDNEY STREET, 15203 PITTSBURGH
Website:: https://cogrx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, small-molecule therapeutics for age-related neurodegenerative disorders. The company's primary mission is to develop disease-modifying drugs that target the underlying cellular damage mechanisms in the brain. Its lead product candidate, zervimesine (CT1812), is an orally administered molecule designed to protect neurons by restoring key cellular processes impaired by toxic proteins. Cognition Therapeutics' research is concentrated on significant central nervous system (CNS) disorders, with primary areas of focus including Alzheimer's disease and dementia with Lewy bodies (DLB), the two most common forms of degenerative dementia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all COGNITION THERAPEUTICS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COGNITION THERAPEUTICS INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for COGNITION THERAPEUTICS INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ASKA Pharmaceutical Holdings CO., Ltd. Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.	Japan	4886
Aspire Biopharma Holdings, Inc. Developing a nano-platform for rapid, sublingual delivery of reformulated medications.	United States of America	ASBP
ASSEMBLY BIOSCIENCES, INC. Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.	United States of America	ASMB
Assertio Holdings, Inc. Offers branded prescription drugs for neurology, pain, and CNS to US patients.	United States of America	ASRT
Astellas Pharma Inc. A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.	Japan	4503
Astena Holdings Co., Ltd. Develops and sells chemicals, pharma, and ingredients for food, cosmetic, and industrial use.	Japan	8095
AstraZeneca PLC Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.	United Kingdom	AZN
ASTRAZENECA PLC Biopharmaceutical firm developing medicines for oncology, rare diseases, and metabolic disorders.	United States of America	AZN
Astria Therapeutics, Inc. Developing long-acting therapies for rare allergic and immunologic diseases like HAE.	United States of America	ATXS
ATAI Life Sciences N.V. Clinical-stage biopharma creating novel psychedelic drugs for mental health disorders.	United States of America	ATAI